Literature DB >> 11529831

Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer.

F D Rahusen1, H Torrenga, P J van Diest, R Pijpers, E van der Wall, J Licht, S Meijer.   

Abstract

BACKGROUND: The potential morbidity of an axillary lymph node dissection in patients with breast cancer can be avoided in patients with a negative sentinel node (SN). HYPOTHESIS: It may be possible to identify a subset of patients with a positive SN and without metastases in the remaining axillary lymph nodes.
DESIGN: Case-control study.
SETTING: Both primary and referral hospital care. PATIENTS: Data were studied for 255 consecutive patients with stage T1 or T2 breast cancer who had a successful identification of the SN.
INTERVENTIONS: In patients with a positive SN, histological examination of all non-SNs that were negative by routine examination was the same as that for SNs (multiple sectioning and immunohistochemical analysis). MAIN OUTCOME MEASURES: The incidence of non-SN metastases was correlated with the surface area and number of SN metastases and primary tumor characteristics. A micrometastasis was defined as less than 1 mm(2).
RESULTS: Of 255 patients, the SN appeared to be positive in 93 (36%). Subsequent axillary lymph node dissection revealed positive non-SNs in 46 patients (49%). Patients with a single positive SN and patients with metastases less than 1 mm(2) in the SN had significantly less non-SN involvement than patients with more than 1 positive SN (40% vs. 78%) and patients with macrometastases (27% vs. 49%).
CONCLUSIONS: The incidence of non-SN metastases seemed to be related to the number of positive SNs and the size of SN metastases. However, in the group of patients with a positive SN, it was not possible to identify a subset of patients without non-SN metastases.

Entities:  

Mesh:

Year:  2001        PMID: 11529831     DOI: 10.1001/archsurg.136.9.1059

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  29 in total

Review 1.  Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance.

Authors:  M A den Bakker; A van Weeszenberg; A Y de Kanter; F H Beverdam; C Pritchard; Th H van der Kwast; M Menke-Pluymers
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

Review 3.  Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: current and resolving controversies on the basis of the European Institute of Oncology experience.

Authors:  Giuseppe Viale; Mauro G Mastropasqua; Eugenio Maiorano; Giovanni Mazzarol
Journal:  Virchows Arch       Date:  2005-11-24       Impact factor: 4.064

4.  Is Completion Axillary Dissection Necessary for This Patient?

Authors:  Sadullah Girgin; Atilla Soran; Nilüfer Güler; Maktav Dinçer; Gökhan Demir
Journal:  J Breast Health       Date:  2014-07-01

5.  Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy.

Authors:  Giuseppe Viale; Eugenio Maiorano; Giancarlo Pruneri; Mauro G Mastropasqua; Stefano Valentini; Viviana Galimberti; Stefano Zurrida; Patrick Maisonneuve; Giovanni Paganelli; Giovanni Mazzarol
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

6.  Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors?

Authors:  J L Fougo; M Afonso; F Senhorães Senra; T Dias; C Leal; C Araújo; M Dinis-Ribeiro
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

7.  Supervised automated microscopy increases sensitivity and efficiency of detection of sentinel node micrometastases in patients with breast cancer.

Authors:  W E Mesker; H Torrenga; W C R Sloos; H Vrolijk; R A E M Tollenaar; P C de Bruin; P J van Diest; H J Tanke
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

8.  Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden.

Authors:  Karyn B Stitzenberg; Anthony A Meyer; Stacey L Stern; William G Cance; Benjamin F Calvo; Nancy Klauber-DeMore; Hong Jin Kim; Leah Sansbury; David W Ollila
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

9.  Sentinel lymph node biopsy in breast cancer patients undergoing skin/nipple-sparing mastectomy and immediate autologous reconstruction.

Authors:  Satoru Tanaka; Takehiro Nohara; Mitsuhiko Iwamoto; Kazuhiro Sumiyoshi; Kosei Kimura; Yuko Takahashi; Nobuhiko Tanigawa
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

10.  Factors Influencing Non-sentinel Node Involvement in Sentinel Node Positive Patients and Validation of MSKCC Nomogram in Indian Breast Cancer Population.

Authors:  Naveen Padmanabhan; Muhamed Faizal Ayub; Khadher Hussain; Ann Kurien; Selvi Radhakrishna
Journal:  Indian J Surg Oncol       Date:  2015-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.